REPORT ID 3951

Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2017

Publish Date
14-Dec-17
Pages
100
Format
Electronic (PDF)

This report studies Glucagon like peptide-1 (GLP-1) agonists in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Novo Nordisk
    AstraZeneca
    Eli Lily
    GSK
    Sanofi
    Bristol-Myers Squibb
    Amylin
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Exenatied
    Liraglutide
    Lixisenatide
    Albiglutide
    Dulaglutide

By Application, the market can be split into
    Hospital
    Pharmacy
    Other

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2017
1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists
    1.1 Definition and Specifications of Glucagon like peptide-1 (GLP-1) agonists
        1.1.1 Definition of Glucagon like peptide-1 (GLP-1) agonists
        1.1.2 Specifications of Glucagon like peptide-1 (GLP-1) agonists
    1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists
        1.2.1 Exenatied
        1.2.2 Liraglutide
        1.2.3 Lixisenatide
        1.2.4 Albiglutide
        1.2.5 Dulaglutide
    1.3 Applications of Glucagon like peptide-1 (GLP-1) agonists
        1.3.1 Hospital
        1.3.2 Pharmacy
        1.3.3 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
    2.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists
    2.4 Industry Chain Structure of Glucagon like peptide-1 (GLP-1) agonists

3 Technical Data and Manufacturing Plants Analysis of Glucagon like peptide-1 (GLP-1) agonists
    3.1 Capacity and Commercial Production Date of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2016

4 Global Glucagon like peptide-1 (GLP-1) agonists Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Glucagon like peptide-1 (GLP-1) agonists Capacity and Growth Rate Analysis
        4.2.2 2016 Glucagon like peptide-1 (GLP-1) agonists Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Analysis
        4.3.2 2016 Glucagon like peptide-1 (GLP-1) agonists Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Glucagon like peptide-1 (GLP-1) agonists Sales Price
        4.4.2 2016 Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis (Company Segment)

5 Glucagon like peptide-1 (GLP-1) agonists Regional Market Analysis
    5.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Analysis
        5.1.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Overview
        5.1.2 North America 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
        5.1.4 North America 2016 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
    5.2 China Glucagon like peptide-1 (GLP-1) agonists Market Analysis
        5.2.1 China Glucagon like peptide-1 (GLP-1) agonists Market Overview
        5.2.2 China 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
        5.2.4 China 2016 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
    5.3 Europe Glucagon like peptide-1 (GLP-1) agonists Market Analysis
        5.3.1 Europe Glucagon like peptide-1 (GLP-1) agonists Market Overview
        5.3.2 Europe 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
        5.3.4 Europe 2016 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
    5.4 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Market Analysis
        5.4.1 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Market Overview
        5.4.2 Southeast Asia 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
        5.4.4 Southeast Asia 2016 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
    5.5 Japan Glucagon like peptide-1 (GLP-1) agonists Market Analysis
        5.5.1 Japan Glucagon like peptide-1 (GLP-1) agonists Market Overview
        5.5.2 Japan 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
        5.5.4 Japan 2016 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
    5.6 India Glucagon like peptide-1 (GLP-1) agonists Market Analysis
        5.6.1 India Glucagon like peptide-1 (GLP-1) agonists Market Overview
        5.6.2 India 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
        5.6.4 India 2016 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis

6 Global 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Sales by Type
    6.2 Different Types of Glucagon like peptide-1 (GLP-1) agonists Product Interview Price Analysis
    6.3 Different Types of Glucagon like peptide-1 (GLP-1) agonists Product Driving Factors Analysis
        6.3.1 Exenatied of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
        6.3.2 Liraglutide of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
        6.3.3 Lixisenatide of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
        6.3.4 Albiglutide of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
        6.3.5 Dulaglutide of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis

7 Global 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Glucagon like peptide-1 (GLP-1) agonists Consumption by Application
    7.2 Different Application of Glucagon like peptide-1 (GLP-1) agonists Product Interview Price Analysis
    7.3 Different Application of Glucagon like peptide-1 (GLP-1) agonists Product Driving Factors Analysis
        7.3.1 Hospital of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
        7.3.2 Pharmacy of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
        7.3.3 Other of Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Glucagon like peptide-1 (GLP-1) agonists
    8.1 Novo Nordisk
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Novo Nordisk 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Novo Nordisk 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
    8.2 AstraZeneca
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 AstraZeneca 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 AstraZeneca 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
    8.3 Eli Lily
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Eli Lily 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Eli Lily 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
    8.4 GSK
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 GSK 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 GSK 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
    8.5 Sanofi
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Sanofi 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Sanofi 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
    8.6 Bristol-Myers Squibb
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Bristol-Myers Squibb 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Bristol-Myers Squibb 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
    8.7 Amylin
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Amylin 2016 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Amylin 2016 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis

9 Development Trend of Analysis of Glucagon like peptide-1 (GLP-1) agonists Market
    9.1 Global Glucagon like peptide-1 (GLP-1) agonists Market Trend Analysis
        9.1.1 Global 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Sales Price Forecast
    9.2 Glucagon like peptide-1 (GLP-1) agonists Regional Market Trend
        9.2.1 North America 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
        9.2.2 China 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
        9.2.3 Europe 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
        9.2.5 Japan 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
        9.2.6 India 2017-2022 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
    9.3 Glucagon like peptide-1 (GLP-1) agonists Market Trend (Product Type)
    9.4 Glucagon like peptide-1 (GLP-1) agonists Market Trend (Application)

10 Glucagon like peptide-1 (GLP-1) agonists Marketing Type Analysis
    10.1 Glucagon like peptide-1 (GLP-1) agonists Regional Marketing Type Analysis
    10.2 Glucagon like peptide-1 (GLP-1) agonists International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Glucagon like peptide-1 (GLP-1) agonists by Region
    10.4 Glucagon like peptide-1 (GLP-1) agonists Supply Chain Analysis

11 Consumers Analysis of Glucagon like peptide-1 (GLP-1) agonists
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source